← All indications
Soft Tissue Neoplasms
Neoplasms of whatever cell type or origin, occurring in the extraskeletal connective tissue framework of the body including the organs of locomotion and their various component structures, such as nerves, blood vessels, lymphatics, etc.
Subtype terms (2)
More specific conditions that are subtypes of Soft Tissue Neoplasms in the MeSH hierarchy.
- Muscle Neoplasms
- Vascular Neoplasms
1 drug approved
Drugs by status
Approved for this indication (1)
Phase 2 trials (2)
Phase 1 trials (5)
Other trials (2)
Organizations
Organization Involved with Phase 3 Indications (1)
Organization Involved with Phase 2 Indications (4)
Organization Involved with Phase 1 Indications (12)
- Eisai
- Leadiant Biosciences, Inc.
- Fondazione Giovanni Pascale
- Wake Forest University
- Wuxi No. 4 People's Hospital
- Medpace, Inc.
- Southern Medical University
- University of Texas at Houston
- Xiangxue Life Science Research Center
- Guangdong Xiangxue Precision Medical Technology Co., Ltd
- Guangzhou Xiangxue Pharmaceutical Co., Ltd
- ImmVira Pharma Co. Ltd